Recorded Chinese product: 注射用转移因子注射用转移因子
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 北京四环科宝制药有限公司Chinese legal name: 北京四环科宝制药有限公司
主要成分Active Ingredients
- 转移因子Zhuanyi Yinzi
药物知识说明
转移因子是一种在国家药监局注册认定的药品。该药品含有转移因子-77957b8f等成分。
该药品关联的活性成分包括：转移因子Zhuanyi Yinzi。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：北京四环科宝制药有限公司Chinese legal name: 北京四环科宝制药有限公司。
您可以探索含有相同成分的其他药品：转移因子-77957b8f成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 注射用转移因子) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 转移因子Zhuanyi Yinzi.
Manufacturers recorded for this product: 北京四环科宝制药有限公司Chinese legal name: 北京四环科宝制药有限公司.
Explore other medicines containing the same ingredient: 转移因子 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 注射用转移因子Recorded Chinese product: 注射用转移因子
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 3mg（多肽）：100ug（核糖）Recorded Chinese description: 3mg（多肽）：100ug（核糖）
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 北京四环科宝制药有限公司Chinese legal name: 北京四环科宝制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20013316
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20013316
Manufacturer
Chinese legal name: 北京四环科宝制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20013316
生产企业
北京四环科宝制药有限公司(国产)
适应症
免疫调节药。|1.本品临床用于治疗病毒性或霉菌性细胞内感染(如带状疱疹，流行性乙型脑炎，白色念珠菌感染，病毒性心肌炎等);|2.对恶性肿瘤可作为辅助治疗剂(主要用于肺癌，鼻咽癌，乳腺癌，骨肉瘤，小儿骨肉瘤等);|3.免疫缺陷病(如湿疹，血小板减少，多次感染综合症及慢性皮肤粘膜真菌病有较好的疗效)。
用法用量
皮下注射:(淋巴回流较丰富的上臂内侧或大腿内侧腹股沟下端为宜，也可皮下注射于上臂三角肌处)，一次1～2支，一周或两周1次或遵医嘱.
不良反应
尚未见有关不良反应报道。
禁忌
对本品过敏者禁用。
注意事项
混浊或变色勿用。
贮藏
密闭，在凉暗处（不超过20℃）保存
规格
3mg（多肽）：100ug（核糖）
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.